A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Sofpironium Bromide Gel, 15% in Subjects with Axillary Hyperhidrosis

Main inclusion criteria:Male or female subject ≥9 years of age in good general health.Diagnosis of primary axillary hyperhidrosis in the opinion of the Investigator that meets all the following criteria:a. HDSM-Ax-72 of 3-4 inclusive at both of the Screening visits (Visits 1 and 4)c. Symptoms of axillary hyperhidrosis for >6 months’ duration

Sponsor(s)
Brickell Biotech
Principal Investigator(s)
Dr. Jonathan Silverberg
Contact Phone Number
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.